LBSUN162 Cumulative Probability Of Heart Failure Hospitalization Among Non-Hispanic Black Compared To Non-Hispanic White Individuals With Type 2 Diabetes On Empagliflozin (EMPA-AA): Real-world Data

The results from the SGLT-2 inhibitors cardiovascular outcome trials were generalized to all, despite that non-Hispanic Black (hereafter, "Black") participants were underrepresented. Our goal was to evaluate, among patients with type 2 diabetes, the risk of heart failure hospitalizations a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishriky, Basem M, Cummings, Doyle M, Fu, Yuanyuan, Halladay, Jacquie, Jones, Schuyler, Boan, Andrea, Jones, Sara, Patil, Shivajirao, Powell, James, Adams, Alyssa, Irish, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Diabetes & Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625019/
http://dx.doi.org/10.1210/jendso/bvac150.582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625019/
http://dx.doi.org/10.1210/jendso/bvac150.582

Ejemplares similares